| Stage | YSWY | % of rev | KR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $921M | 100.00% | $34.6B | 100.00% | KR ×37.60 |
| Gross profit | $122M | 13.22% | $7.9B | 22.70% | KR +9.5pp |
| Operating income | $48M | 5.19% | $971M | 2.80% | YSWY +2.4pp |
| Pre-tax income | $36M | 3.89% | $840M | 2.43% | YSWY +1.5pp |
| Net income | $30M | 3.22% | $642M | 1.85% | YSWY +1.4pp |
| Stage | YSWY | KR | Gap · A − B |
|---|---|---|---|
| Revenue | $921M100.00% | $34.6B100.00% | KR ×37.60 |
| Gross profit | 13.22%$122M | 22.70%$7.9B | KR +9.5pp |
| Operating income | 5.19%$48M | 2.80%$971M | YSWY +2.4pp |
| Pre-tax income | 3.89%$36M | 2.43%$840M | YSWY +1.5pp |
| Net income |
| 3.22%$30M |
| 1.85%$642M |
| YSWY +1.4pp |
No shared counterparties.